Physician profile
Sean Behan
NPI 1144726639
$2,205.50
in general payments reported to CMS, 2019-2025
19 companies · $37.68 in 2025
The $37.68 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $319 · 2023: $1,366 · 2024: $330 · 2025: $37.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,688 · Education: $46.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,687.61 |
| Education | $46.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $351.28 | 2022-2024 | |
| Amgen INC. | $267.09 | 2023-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.68 | 2021-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $202.91 | 2022-2024 | Xarelto |
| Medtronic, INC. | $194.50 | 2022-2025 | Selectsecure, Cobalt Dr Mri Surescan, Micra |
| Astrazeneca Pharmaceuticals LP | $174.57 | 2021-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.29 | 2023-2024 | Jardiance |
| Boston Scientific Corporation | $99.88 | 2022-2023 | Watchman Access System |
| Edwards Lifesciences Corporation | $95.04 | 2022 | |
| Zoll Circulation INC | $94.25 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Pfizer INC. | $70.32 | 2023-2024 | |
| Abbott Laboratories | $66.79 | 2022-2024 | Cardiomems |
| Merck Sharp & Dohme LLC | $46.35 | 2023 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $37.92 | 2023 | Uptravi |
| Shockwave Medical, INC | $28.00 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $23.80 | 2024 | |
| Teleflex LLC | $18.06 | 2023 | Warrior |
| E.R. Squibb & Sons, L.L.C. | $17.11 | 2023 | Camzyos |
| Chiesi USA, INC. | $16.66 | 2024 | Kengreal, Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Behan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.